InsiderPulse| Date | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-29 | MOULDER LEON O JR | Director & Chief Executive Officer | Purchase | 35.0K | $17.62 | $617K | 1.79M | View ↗ | |
| 2026-04-28 | MOULDER LEON O JR | Director & Chief Executive Officer | Purchase | 25.0K | $18.02 | $451K | 1.75M | View ↗ | |
| 2026-03-31 | Lu Hongbo | Director | Purchase | 78.8K | $19.93 | $1.57M | 426.7K | View ↗ | |
| 2026-03-31 | Fairmount Funds Management LLC | Director | Purchase | 150.0K | $20.00 | $3.00M | 2.36M | View ↗ | |
| 2026-03-31 | MOULDER LEON O JR | Director & Chief Executive Officer | Purchase | 34.0K | $19.31 | $657K | 1.73M | View ↗ |
No annual data found.
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Insiders Are Scooping Up These 2 ‘Strong Buy’ Stocks
Zenas BioPharma's Key Milestones And Market Context: Holding Through The BLA
Zenas BioPharma Funding Shifts Focus From Survival Risk To Execution Risk